Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
ADC Therapeutics
Biotech
New year, new C-suite execs—Chutes & Ladders
The biopharma world rang in the new year with new faces and C-suite exits at Moderna, Biogen, Galapagos, Zymeworks and more
Gabrielle Masson
,
Max Bayer
Jan 6, 2023 9:30am
ADC therapy sidelined after FDA nixes accelerated review chance
Nov 8, 2022 10:25am
Rubius execs depart as the walls close in—Chutes & Ladders
Nov 4, 2022 9:30am
Pheon hauls in $68M series A off the excitement of budding ADCs
Sep 28, 2022 3:00am
Biotech's 2022 gender diversity track record—Chutes & Ladders
Jun 17, 2022 9:30am
ADC Therapeutics scores high response for Hodgkin lymphoma drug
Jun 10, 2022 11:27am